BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10091728)

  • 41. [Identification of new substrates of cyclin-activated kinases in breast cancers].
    Lilischkis R; Barczak E; Marwedel M; Mehraein Y; Lauterlein M; Lüscher B; Kreipe H
    Verh Dtsch Ges Pathol; 2001; 85():269-74. PubMed ID: 11894409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer.
    Yamamoto H; Monden T; Ikeda K; Izawa H; Fukuda K; Fukunaga M; Tomita N; Shimano T; Shiozaki H; Monden M
    Br J Cancer; 1995 Jun; 71(6):1231-6. PubMed ID: 7779716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Telomerase activity correlates with cell cycle regulators in human hepatocellular carcinoma.
    Hsieh HF; Harn HJ; Chiu SC; Liu YC; Lui WY; Ho LI
    Liver; 2000 Apr; 20(2):143-51. PubMed ID: 10847483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p107 Expression in colorectal tumours rises during carcinogenesis and falls during invasion.
    Wu F; Li JQ; Miki H; Nishioka M; Fujita J; Ohmori M; Imaida K; Kuriyama S
    Eur J Cancer; 2002 Sep; 38(14):1838-48. PubMed ID: 12204665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas.
    Kitahara K; Yasui W; Kuniyasu H; Yokozaki H; Akama Y; Yunotani S; Hisatsugu T; Tahara E
    Int J Cancer; 1995 Jul; 62(1):25-8. PubMed ID: 7601562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tyrosine phosphorylation in mouse mammary hyperplasias.
    Said TK; Medina D
    Carcinogenesis; 1995 Apr; 16(4):923-30. PubMed ID: 7728975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between the expressions of gastrin, somatostatin and cyclin and cyclin-depend kinase in colorectal cancer.
    Wu P; Mao JD; Yan JY; Rui J; Zhao YC; Li XH; Xu GQ
    World J Gastroenterol; 2005 Dec; 11(45):7211-7. PubMed ID: 16437675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression.
    Marone M; Scambia G; Giannitelli C; Ferrandina G; Masciullo V; Bellacosa A; Benedetti-Panici P; Mancuso S
    Int J Cancer; 1998 Jan; 75(1):34-9. PubMed ID: 9426687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell cycle regulators during human atrial development.
    Kim WH; Joo CU; Ku JH; Ryu CH; Koh KN; Koh GY; Ko JK
    Korean J Intern Med; 1998 Jul; 13(2):77-82. PubMed ID: 9735660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteomic co-expression of cyclin-dependent kinases 1 and 4 in human cancer cells.
    Seabra L; Warenius H
    Eur J Cancer; 2007 Jun; 43(9):1483-92. PubMed ID: 17481885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of cyclins and cyclin-dependent kinases in smooth muscle tumors of the uterus.
    Zhai YL; Nikaido T; Shiozawa T; Orii A; Fujii S
    Int J Cancer; 1999 Jun; 84(3):244-50. PubMed ID: 10371341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A sporadic, atypical case of desminopathy: morphological and immunological characterization.
    Prelle A; Sciacco M; Comi GP; Messina S; Carpo M; Ciscato P; Nobile Orazio E; Fortunato F; Mora G; Bignotti V; Fagiolari G; Moggio M; Scarlato G
    Clin Neuropathol; 2000; 19(4):208-12. PubMed ID: 10919353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections.
    Ikeda K; Monden T; Kanoh T; Tsujie M; Izawa H; Haba A; Ohnishi T; Sekimoto M; Tomita N; Shiozaki H; Monden M
    J Histochem Cytochem; 1998 Mar; 46(3):397-403. PubMed ID: 9487122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting cyclin-dependent kinases in Drosophila with peptide aptamers.
    Kolonin MG; Finley RL
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14266-71. PubMed ID: 9826689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional characterisation of cell cycle-related kinase (CCRK) in colorectal cancer carcinogenesis.
    An X; Ng SS; Xie D; Zeng YX; Sze J; Wang J; Chen YC; Chow BK; Lu G; Poon WS; Kung HF; Wong BC; Lin MC
    Eur J Cancer; 2010 Jun; 46(9):1752-61. PubMed ID: 20466538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Promising Anticancer Activity of Multitarget Cyclin Dependent Kinase Inhibitors against Human Colorectal Carcinoma Cells.
    Manohar SM; Joshi KS
    Curr Mol Pharmacol; 2022; 15(7):1024-1033. PubMed ID: 35068399
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression and prognostic value of transcription-associated cyclin-dependent kinases in human breast cancer.
    Li N; Zheng S; Xue Z; Xiong Z; Zou Y; Tang Y; Wei WD; Yang L
    Aging (Albany NY); 2021 Mar; 13(6):8095-8114. PubMed ID: 33686962
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different expression patterns of cyclins A, D1 and E in human colorectal cancer.
    Wang A; Yoshimi N; Suzui M; Yamauchi A; Tarao M; Mori H
    J Cancer Res Clin Oncol; 1996; 122(2):122-6. PubMed ID: 8576279
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aspirin metabolites 2,3‑DHBA and 2,5‑DHBA inhibit cancer cell growth: Implications in colorectal cancer prevention.
    Sankaranarayanan R; Valiveti CK; Dachineni R; Kumar DR; Lick T; Bhat GJ
    Mol Med Rep; 2020 Jan; 21(1):20-34. PubMed ID: 31746356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CCNG2 expression is downregulated in colorectal carcinoma and its clinical significance.
    Sun GG; Zhang J; Hu WN
    Tumour Biol; 2014 Apr; 35(4):3339-46. PubMed ID: 24307622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.